Organization · Venture Capital
M3A HealthTech Venture Fund
M3A HealthTech Venture Fund invests in early-stage healthcare companies, focusing on the intersection of innovative technology and clinical insight. The team has extensive experience in building and exiting transformative healthcare companies.
Overview
What M3A HealthTech Venture Fund does
What M3A HealthTech Venture Fund is
M3A HealthTech Venture Fund invests in early-stage healthcare companies, focusing on the intersection of innovative technology and clinical insight. The team has extensive experience in building and exiting transformative healthcare companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find M3A HealthTech Venture Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
M3A HealthTech Venture Fund as a funder
Investment thesis
M3A HealthTech Venture Fund focuses on seed-stage investments in innovative healthcare solutions, particularly in MedTech and artificial intelligence. The firm partners with founders who have clinical insights and technological expertise to enhance healthcare delivery.
Focus narrative
M3A invests in early-stage companies within the healthcare technology space, specifically targeting sectors such as medical devices and AI. Their investment strategy emphasizes collaboration with founders to scale solutions that enhance healthcare delivery, ensuring that innovative technologies reach the market effectively.
Focus and fit
- Stages
- Seed
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 5
Portfolio context
Alt-Bionics: Develops affordable, high-performance bionic hands aimed at improving accessibility to advanced robotics for everyday patients. Alt-Bionics Website Lyten: Focuses on reinventing medical materials using 3D-graphene chemistry to enhance the performance of devices and sensors. Lyten Website Altus-X: An AI-enhanced hemophilia therapy platform that engineers smarter, more durable clotting molecules for improved patient care. Altus-X Website NearWave: Provides AI-enhanced optical imaging technology that offers clinicians real-time, noninvasive insights into tissue health and treatment responses. NearWave Website VisionOR: An Apple-native surgical operating system that utilizes real-time AI and computer vision to optimize workflows and performance in operating rooms. VisionOR Website
Common questions
What to know about M3A HealthTech Venture Fund
Upseed classifies M3A HealthTech Venture Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.